Thursday 30 April 2009

Phenergan




In the US, Phenergan (promethazine systemic) is a member of the following drug classes: antihistamines, phenothiazine antiemetics and is used to treat Allergic Reactions, Anaphylaxis, Hay Fever, Light Sedation, Motion Sickness, Nausea/Vomiting, Opiate Adjunct, Sedation, Urticaria and Vertigo.

US matches:

  • Phenergan

  • Phenergan Suppositories

  • Phenergan Tablets

  • Phenergan VC

  • Phenergan injection

  • Phenergan rectal

  • Phenergan Injection, Intravenous

UK matches:

  • Phenergan 10mg Tablets (SPC)
  • Phenergan 25 mg tablets (SPC)
  • Phenergan Elixir (SPC)

Ingredient matches for Phenergan



Promethazine

Promethazine hydrochloride (a derivative of Promethazine) is reported as an ingredient of Phenergan in the following countries:


  • Australia

  • Bahrain

  • Bangladesh

  • Belgium

  • Denmark

  • Egypt

  • Ghana

  • Iceland

  • India

  • Iran

  • Iraq

  • Ireland

  • Jordan

  • Kenya

  • Kuwait

  • Lebanon

  • Luxembourg

  • Malta

  • New Zealand

  • Nigeria

  • Norway

  • Oman

  • Qatar

  • Saudi Arabia

  • South Africa

  • Syria

  • Thailand

  • United Arab Emirates

  • United Kingdom

  • Vietnam

  • Yemen

  • Zimbabwe

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday 27 April 2009

Co-Zartan




Co-Zartan may be available in the countries listed below.


Ingredient matches for Co-Zartan



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Co-Zartan in the following countries:


  • Tunisia

Losartan

Losartan is reported as an ingredient of Co-Zartan in the following countries:


  • Tunisia

International Drug Name Search

Saturday 25 April 2009

Paracetamol Iqfarma




Paracetamol Iqfarma may be available in the countries listed below.


Ingredient matches for Paracetamol Iqfarma



Paracetamol

Paracetamol is reported as an ingredient of Paracetamol Iqfarma in the following countries:


  • Peru

International Drug Name Search

Friday 24 April 2009

POR 8 Ferring




POR 8 Ferring may be available in the countries listed below.


Ingredient matches for POR 8 Ferring



Ornipressin

Ornipressin is reported as an ingredient of POR 8 Ferring in the following countries:


  • New Zealand

International Drug Name Search

Thursday 23 April 2009

Relnate DHA





Dosage Form: capsule, liquid filled
RELNATE

DHA

PRENATAL / MULTIVITAMIN


Rev. 3/11






























Softgels
Omega-3

  Fatty Acids (DHA-EPA)
200mg
Vitamin B1

  (Thiamine Mononitrate)
3 mg
Vitamin B2

  (Riboflavin)
3 mg
Vitamin B6

  (Pyridoxine HCL)
20 mg
Vitamin B12

  (Cyanocobalamin)
15 mcg
Folic Acid1 mg
Vitamin D3

  (Cholecalciferol)
400 IU
Vitamin C

  (Ascorbic Acid)
100 IU
Vitamin E

  (d-alpha tocopherol)
30 IU
Mineral Copper

  (Sulfate)
1 mg
Zinc

  (Zinc Oxide)
20 mg
Iron

  (Fumerate)
28 mg
Magnesium30 mg

Rx ONLY



Description


Each Softgel Contains:




























Omega-3

  Fatty Acids (DHA-EPA)
200mg
Vitamin B1

  (Thiamine Mononitrate)
3 mg
Vitamin B2

  (Riboflavin)
3 mg
Vitamin B6

  (Pyridoxine HCL)
20 mg
Vitamin B12

  (Cyanocobalamin)
15 mcg
Folic Acid1 mg
Vitamin D3

  (Cholecalciferol)
400 IU
Vitamin C

  (Ascorbic Acid)
100 IU
Vitamin E

  (d-alpha tocopherol)
30 IU
Mineral Copper

  (Sulfate)
1 mg
Zinc

  (Zinc Oxide)
20 mg
Iron

  (Fumerate)
28 mg
Magnesium30 mg

INACTIVE INGREDIENTS


Gelatin, Glycerine, purified water, annatto extract, lecithin, yellow beeswax, titanium dioxide.



Indications and Usage for Relnate DHA


Relnate DHA is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of woman prior to conception, throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers.



Contraindications


Relnate DHA should not be used by patients with known history of hypersensitivity to any of the listed ingredients.



Precautions


Folic Acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic Acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.



Warning


Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.



PEDIACTRIC USE


Safety and effectiveness in pediactric patients has not been established.



GERIACTRIC USE


No clinical studies have been performed in patients over 65 to determine whether older persons respond differently from younger persons. Physicians should consider that elderly person may have decreased hepatic, renal, or cardiac function.



Drug Interactions


Relnate DHA softgels are not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine.



ADVERSE REACTION


Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.



Relnate DHA Dosage and Administration


Usual adult dose: one softgel daily or as prescribed by your doctor.



How is Relnate DHA Supplied


Relnate DHA is available as a Annato colored softgel, imprinted PRE 01. Available in 30 count bottles with NDC #35573-103-30 and sample cartons with NDC #35573-103-05.


NDC # 35573-103-05 PHYSICIAN SAMPLE NOT FOR RESALE



Recommended Storage 59-86 degrees (F). Protect from light moisture and avoid excessive heat. Dispense original carton.


KEEP OUT OF REACH OF CHILDREN



RX ONLY


BUREL

PHARMACEUTICALS

JACKSON, MS 39218



PRINCIPAL DISPLAY PANEL - 30 Soft gel Bottle Label


NDC 35573-200-30


Relnate

DHA




























Omega-3 Fatty Acids (DHA-EPA)200 mg
Vitamin B1 (Thiamine Mononitrate)3 mg
Vitamin B2 (Riboflavin)3 mg
Vitamin B6 (Pyridoxine HCL)20 mg
Vitamin B12 (Cyanocobalamin)15 mcg
Folic Acid1 mg
Vitamin D3 (Cholecalciferol)400 IU
Vitamin C (Ascorbic Acid)100 mg
Vitamin E (d-alpha tocopherol)30 IU
Copper (Cupric Sulfate)1 mg
Zinc (Zinc Oxide)20 mg
Iron (Fumerate)28 mg
Magnesium30 mg

Rx Only


Net Contents: 30 Soft gels










Relnate DHA 
omega-3 fatty acids, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, folic acid, cholecalciferol, ascorbic acid, alpha-tocopherol, cupric sulfate anhydrous, zinc oxide, iron, and magnesium  capsule, liquid filled










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)35573-103
Route of AdministrationORALDEA Schedule    












































Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OMEGA-3 FATTY ACIDS (OMEGA-3 FATTY ACIDS)OMEGA-3 FATTY ACIDS200 mg
THIAMINE MONONITRATE (THIAMINE)THIAMINE MONONITRATE3 mg
RIBOFLAVIN (RIBOFLAVIN)RIBOFLAVIN3 mg
PYRIDOXINE HYDROCHLORIDE (PYRIDOXINE)PYRIDOXINE HYDROCHLORIDE20 mg
CYANOCOBALAMIN (CYANOCOBALAMIN)CYANOCOBALAMIN15 ug
FOLIC ACID (FOLIC ACID)FOLIC ACID1 mg
CHOLECALCIFEROL (CHOLECALCIFEROL)CHOLECALCIFEROL400 [iU]
ASCORBIC ACID (ASCORBIC ACID)ASCORBIC ACID100 mg
ALPHA-TOCOPHEROL (ALPHA-TOCOPHEROL)ALPHA-TOCOPHEROL30 [iU]
CUPRIC SULFATE ANHYDROUS (SULFATE ION)CUPRIC SULFATE ANHYDROUS1 mg
ZINC OXIDE (ZINC OXIDE)ZINC OXIDE20 mg
IRON (IRON)IRON28 mg
MAGNESIUM (MAGNESIUM)MAGNESIUM30 mg
















Inactive Ingredients
Ingredient NameStrength
Gelatin 
Glycerin 
Water 
Bixa Orellana Seed 
Yellow Wax 
Titanium Dioxide 


















Product Characteristics
ColorRED (Annato colored)Scoreno score
ShapeCAPSULESize14mm
FlavorImprint CodePRE;01
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
135573-103-051 BOTTLE In 1 CARTONcontains a BOTTLE (35573-103-30)
135573-103-3030 CAPSULE In 1 BOTTLEThis package is contained within the CARTON (35573-103-05)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
UNAPPROVED DRUG OTHER05/15/2011







Relnate DHA 
omega-3 fatty acids, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, cyanocobalamin, folic acid, cholecalciferol, ascorbic acid, alpha-tocopherol, cupric sulfate anhydrous, zinc oxide, iron, and magnesium  capsule, liquid filled










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)35573-200
Route of AdministrationORALDEA Schedule    












































Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OMEGA-3 FATTY ACIDS (OMEGA-3 FATTY ACIDS)OMEGA-3 FATTY ACIDS200 mg
THIAMINE MONONITRATE (THIAMINE)THIAMINE MONONITRATE3 mg
RIBOFLAVIN (RIBOFLAVIN)RIBOFLAVIN3 mg
PYRIDOXINE HYDROCHLORIDE (PYRIDOXINE)PYRIDOXINE HYDROCHLORIDE20 mg
CYANOCOBALAMIN (CYANOCOBALAMIN)CYANOCOBALAMIN15 ug
FOLIC ACID (FOLIC ACID)FOLIC ACID1 mg
CHOLECALCIFEROL (CHOLECALCIFEROL)CHOLECALCIFEROL400 [iU]
ASCORBIC ACID (ASCORBIC ACID)ASCORBIC ACID100 [iU]
ALPHA-TOCOPHEROL (ALPHA-TOCOPHEROL)ALPHA-TOCOPHEROL30 [iU]
CUPRIC SULFATE ANHYDROUS (SULFATE ION)CUPRIC SULFATE ANHYDROUS1 mg
ZINC OXIDE (ZINC OXIDE)ZINC OXIDE20 mg
IRON (IRON)IRON28 mg
MAGNESIUM (MAGNESIUM)MAGNESIUM30 mg
















Inactive Ingredients
Ingredient NameStrength
Gelatin 
Glycerin 
Water 
Bixa Orellana Seed 
Yellow Wax 
Titanium Dioxide 


















Product Characteristics
ColorRED (Annato colored)Scoreno score
ShapeCAPSULESize14mm
FlavorImprint CodePRE;01
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
135573-200-3030 CAPSULE In 1 BOTTLENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
UNAPPROVED DRUG OTHER05/15/2011


Labeler - Burel Pharmaceuticals, LLC (002152814)
Revised: 05/2011Burel Pharmaceuticals, LLC



Wednesday 22 April 2009

Cholografin Meglumine




In the US, Cholografin Meglumine (iodipamide systemic) is a member of the drug class ionic iodinated contrast media.

US matches:

  • Cholografin Meglumine

Ingredient matches for Cholografin Meglumine



Adipiodone

Adipiodone meglumine (a derivative of Adipiodone) is reported as an ingredient of Cholografin Meglumine in the following countries:


  • United States

International Drug Name Search

Monday 20 April 2009

Interlansil




Interlansil may be available in the countries listed below.


Ingredient matches for Interlansil



Lansoprazole

Lansoprazole is reported as an ingredient of Interlansil in the following countries:


  • Vietnam

International Drug Name Search

Saturday 18 April 2009

Anfotericina B Bestpharma




Anfotericina B Bestpharma may be available in the countries listed below.


Ingredient matches for Anfotericina B Bestpharma



Amphotericin B

Amphotericin B is reported as an ingredient of Anfotericina B Bestpharma in the following countries:


  • Peru

International Drug Name Search

Methoxacet




Methoxacet may be available in the countries listed below.


Ingredient matches for Methoxacet



Methocarbamol

Methocarbamol is reported as an ingredient of Methoxacet in the following countries:


  • Canada

Paracetamol

Paracetamol is reported as an ingredient of Methoxacet in the following countries:


  • Canada

International Drug Name Search

Citicoline OGBdexa




Citicoline OGBdexa may be available in the countries listed below.


Ingredient matches for Citicoline OGBdexa



Citicoline

Citicoline is reported as an ingredient of Citicoline OGBdexa in the following countries:


  • Indonesia

International Drug Name Search

Tuesday 14 April 2009

Inpepsa




Inpepsa may be available in the countries listed below.


Ingredient matches for Inpepsa



Sucralfate

Sucralfate is reported as an ingredient of Inpepsa in the following countries:


  • Indonesia

International Drug Name Search

Saturday 11 April 2009

Romal




Romal may be available in the countries listed below.


Ingredient matches for Romal



Ketoprofen

Ketoprofen is reported as an ingredient of Romal in the following countries:


  • Japan

International Drug Name Search

Friday 10 April 2009

Eftil




Eftil may be available in the countries listed below.


Ingredient matches for Eftil



Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Eftil in the following countries:


  • Serbia

International Drug Name Search

Friday 3 April 2009

Supracyclin




Supracyclin may be available in the countries listed below.


Ingredient matches for Supracyclin



Doxycycline

Doxycycline monohydrate (a derivative of Doxycycline) is reported as an ingredient of Supracyclin in the following countries:


  • Luxembourg

  • Peru

  • Switzerland

International Drug Name Search

Thursday 2 April 2009

b-dihydroartemisinin




b-dihydroartemisinin may be available in the countries listed below.


Ingredient matches for b-dihydroartemisinin



Artenimol

b-dihydroartemisinin (Ph. Int.) is also known as Artenimol (Rec.INN)

International Drug Name Search

Glossary

Ph. Int.Pharmacopoea Internationalis
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.